Risk factor
Resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Zhejiang Yongtai Technology Co., Ltd., which commenced operations in 1999 and is headquartered in Linhai, China, primarily focuses on the innovation, production, and distribution of fluorine-based chemicals throughout the country. The company's offerings include fluorinated compounds essential for pharmaceutical applications, serving a wide array of medicinal fields such as anti-diabetic, antiviral, cardiovascular, quinolone-type antibacterial, and nervous system treatments. Additionally, they provide chemical intermediates utilized in the formulation of insecticides and fungicides. Furthermore, Zhejiang Yongtai Technology diversifies its portfolio with materials for liquid crystal displays, lithium-ion batteries, and various other energy-related products. They also extend custom manufacturing solutions to partners within the pharmaceutical and general chemical sectors.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI